The central theme for this year’s congress is “Artificial Intelligence and New Technology in Radiation Oncology.” This event aims to foster advancements in oncological care, with a particular emphasis on the integration of AI and innovative technologies in radiation oncology.

The congress will bring together a diverse group of professionals, including radiation oncologists, medical oncologists, physicists, dosimetrists, therapists, clinical engineers, and nurses from across the region and beyond. Sessions will focus on training, research, and patient care, with international and national keynote speakers presenting the latest studies and technological developments.

Attendees can expect a comprehensive scientific program, including breakout sessions tailored to specific tumor sites, podium presentations, poster sessions, and educational opportunities with CME accreditation. Topics will cover a wide spectrum, such as AI applications in oncology, radiotherapy, brachytherapy, advanced physics, immunotherapy, targeted therapy, and more.

The Middle East Society of Therapeutic Radiation and Oncology (MESTRO) is dedicated to promoting international standards and best practices in radiotherapy and oncology, with the ultimate goal of improving patient care throughout the Middle East. Through collaboration, education, and research, MESTRO strives to elevate the standards of treatment and awareness in the region.

We invite you to register and submit your abstracts via the provided link, and encourage you to share this information with colleagues who may be interested in attending. We look forward to welcoming you to Riyadh for an engaging and productive meeting.

On behalf of the Scientific Committee,
Dr. Saad Alrashidi, Congress Chair
Professor Khalid Alkattan, Congress  Organizer & Treasurer